Literature DB >> 25273858

Hypertension prevalence, awareness, treatment and control in Germany 1998 and 2008-11.

H K Neuhauser1, C Adler1, A S Rosario2, C Diederichs1, U Ellert2.   

Abstract

Germany was reported to have higher blood pressure (BP) and lower awareness, treatment and control of BP than other western countries based on 1998 data. BP distribution and hypertension management were examined for 1998 and 2008-11 in 7108 adult participants of the German National Health Interview and Examination Survey 1998 (GNHIES98) and in 7095 adult participants the German Health Interview and Examination Survey for Adults 2008-11 (DEGS1) aged 18-79 years. Age- and sex-standardized mean systolic BP (SBP) dropped from 129.0 to 124.1 mm Hg (women 127.3-120.8, men 130.7-127.4), mean diastolic BP (DBP) from 78.3 to 73.2 mm Hg (women 78.0-71.2, men 78.5-75.3). Mean SBP and DBP decreased most in treated hypertensives but were also lower in participants without hypertension. The overall prevalence of hypertension, including controlled hypertension, remained almost unchanged (30% vs 32%). Uncontrolled hypertension (BP⩾140/90 mm Hg) decreased from 23% to 15% (women 22-13%, men 24-18%). Among hypertensives, awareness increased from 69% to 82% (women 74-87%, men 65-78%), treatment increased from 55% to 72% (women 62-79%, men 48-65%) and control increased from 23% to 51% (women 25-58%, men 20-45%). However, men aged 18-29 years had an opposite trend with 1.5 mm Hg higher SBP and increased prevalence of hypertension, which was mostly uncontrolled. These findings suggest that BP has decreased substantially in Germany, while leaving a persistent gender gap in management and room for further improvement of prevention and treatment, particularly in men.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25273858     DOI: 10.1038/jhh.2014.82

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  21 in total

1.  Evaluation of the Datascope Accutorr Plus according to the recommendations of the Association for the Advancement of Medical Instrumentation.

Authors: 
Journal:  Blood Press Monit       Date:  1997-04       Impact factor: 1.444

2.  European Society of Hypertension International Protocol revision 2010 for the validation of blood pressure measuring devices in adults.

Authors:  Eoin O'Brien; Neil Atkins; George Stergiou; Nikos Karpettas; Gianfranco Parati; Roland Asmar; Yutaka Imai; Jiguang Wang; Thomas Mengden; Andrew Shennan
Journal:  Blood Press Monit       Date:  2010-02       Impact factor: 1.444

3.  US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008.

Authors:  Brent M Egan; Yumin Zhao; R Neal Axon
Journal:  JAMA       Date:  2010-05-26       Impact factor: 56.272

4.  [Physical activity: results of the German Health Interview and Examination Survey for Adults (DEGS1)].

Authors:  S Krug; S Jordan; G B M Mensink; S Müters; J Finger; T Lampert
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2013-05       Impact factor: 1.513

5.  Trends in coronary risk factors in the WHO MONICA project.

Authors:  A Evans; H Tolonen; H W Hense; M Ferrario; S Sans; K Kuulasmaa
Journal:  Int J Epidemiol       Date:  2001-10       Impact factor: 7.196

6.  Calibration of blood pressure data after replacement of the standard mercury sphygmomanometer by an oscillometric device and concurrent change of cuffs.

Authors:  Hannelore K Neuhauser; Ute Ellert; Michael Thamm; Carolin Adler
Journal:  Blood Press Monit       Date:  2015-02       Impact factor: 1.444

7.  [Fruit and vegetable intake in Germany: results of the German Health Interview and Examination Survey for Adults (DEGS1)].

Authors:  G B M Mensink; J Truthmann; M Rabenberg; C Heidemann; M Haftenberger; A Schienkiewitz; A Richter
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2013-05       Impact factor: 1.513

8.  Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States.

Authors:  Katharina Wolf-Maier; Richard S Cooper; José R Banegas; Simona Giampaoli; Hans-Werner Hense; Michel Joffres; Mika Kastarinen; Neil Poulter; Paola Primatesta; Fernando Rodríguez-Artalejo; Birgitta Stegmayr; Michael Thamm; Jaakko Tuomilehto; Diego Vanuzzo; Fenicia Vescio
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

9.  Hypertension treatment and control in five European countries, Canada, and the United States.

Authors:  Katharina Wolf-Maier; Richard S Cooper; Holly Kramer; José R Banegas; Simona Giampaoli; Michel R Joffres; Neil Poulter; Paola Primatesta; Birgitta Stegmayr; Michael Thamm
Journal:  Hypertension       Date:  2003-11-24       Impact factor: 10.190

10.  National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5·4 million participants.

Authors:  Goodarz Danaei; Mariel M Finucane; John K Lin; Gitanjali M Singh; Christopher J Paciorek; Melanie J Cowan; Farshad Farzadfar; Gretchen A Stevens; Stephen S Lim; Leanne M Riley; Majid Ezzati
Journal:  Lancet       Date:  2011-02-03       Impact factor: 79.321

View more
  51 in total

1.  [Prevention of Alzheimer's dementia in Germany : A projection of the possible potential of reducing selected risk factors].

Authors:  T Luck; S G Riedel-Heller
Journal:  Nervenarzt       Date:  2016-11       Impact factor: 1.214

2.  Changes in prevalence, awareness, treatment and control of hypertension in disadvantaged French Caribbean populations, 2003 to 2014.

Authors:  P Carrère; N Halbert; S Lamy; J Inamo; A Atallah; T Lang
Journal:  J Hum Hypertens       Date:  2017-04-13       Impact factor: 3.012

Review 3.  [Antihypertensive therapy in the elderly].

Authors:  J Schrader; B Schrader
Journal:  Herz       Date:  2018-05       Impact factor: 1.443

4.  From prescription-only (Rx) to over-the-counter (OTC) status in Germany 2006-2015: pharmacological perspectives on regulatory decisions.

Authors:  Eva Barrenberg; Edeltraut Garbe
Journal:  Eur J Clin Pharmacol       Date:  2017-03-28       Impact factor: 2.953

Review 5.  Antihypertensive Combination Treatment: State of the Art.

Authors:  M Burnier
Journal:  Curr Hypertens Rep       Date:  2015-07       Impact factor: 5.369

Review 6.  Multidisciplinary Approach in the Treatment of Resistant Hypertension.

Authors:  S A Potthoff; O Vonend
Journal:  Curr Hypertens Rep       Date:  2017-01       Impact factor: 5.369

7.  Hypertension in Germany.

Authors:  Hannelore Neuhauser; Claudia Diederichs; Heiner Boeing; Stephan B Felix; Claus Jünger; Roberto Lorbeer; Christine Meisinger; Annette Peters; Henry Völzke; Cornelia Weikert; Philipp Wild; Marcus Dörr
Journal:  Dtsch Arztebl Int       Date:  2016-12-02       Impact factor: 5.594

8.  The persisting gender gap in hypertension management and control in Germany: 1998 and 2008-2011.

Authors:  Giselle Sarganas; Hannelore K Neuhauser
Journal:  Hypertens Res       Date:  2016-01-28       Impact factor: 3.872

Review 9.  Changes in Hypertension Prevalence, Awareness, Treatment, and Control in High-, Middle-, and Low-Income Countries: An Update.

Authors:  Renata Cifkova; George Fodor; Peter Wohlfahrt
Journal:  Curr Hypertens Rep       Date:  2016-08       Impact factor: 5.369

10.  Arterial Hypertension.

Authors:  Jens Jordan; Christine Kurschat; Hannes Reuter
Journal:  Dtsch Arztebl Int       Date:  2018-08-20       Impact factor: 5.594

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.